Blood product required for the treatment of TTP patients
Octaplas, blood product required for the treatment of TTP patients. CMU National Framework Agreement for the supply of products for the treatment of Bleeding Disorders including Haemophilia B Offer reference number: CM/PHS/19/5576
Buyer
University Hospitals of Leicester NHS Trust
Value
£97,500
Published
3 Aug 2022
Closes
1 Jun 2022
Procurement details
Source
Contracts Finder
Region
United Kingdom
Procurement method
Selective
Category
Goods
Contract starts
30 Jun 2022
Contract ends
30 Jun 2024
CPV classifications
33141510
Blood products
Lots
Lot default Blood product required for the treatment of TTP patients
£97,500
Octaplas, blood product required for the treatment of TTP patients. CMU National Framework Agreement for the supply of products for the treatment of Bleeding Disorders including Haemophilia B Offer reference number: CM/PHS/19/5576
Delivery: East Midlands · United Kingdom, East Midlands, United Kingdom
Documents
Unlock document linkAwarded contract notice on Contracts Finder
3 Aug 2022
Awarded contract notice on Contracts Finder
Award notice · Web page
Contains public sector information licensed under the Open Government Licence v3.0.